IDEXX Laboratories, Inc. vs Pfizer, Inc. — Stock Comparison

IDXX
IDEXX Laboratories, Inc.
$567.46
▲ 1.19%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
IDEXX Laboratories, Inc.
IDXX7.5/10vs 6.5/10

Q·Score Breakdown

7.5
Bullish
Overall
6.5
Neutral
9
Quality
7.4
7
Health
7
7.9
Growth
5.6
6.6
Valuation
6.7
6.4
Sentiment
5.2
IDXX

High-quality business with 66% return on equity and 25% profit margins.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $724.50 (+27.7%)
14 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

IDXX
PFE
43.3×
Trailing P/E
19.4×
34.6×
Forward P/E
9.4×
24.6%
Profit Margin
12.4%
61.8%
Gross Margin
75.8%
66.2%
ROE
8.9%
14.3%
Revenue Growth
-1.2%
17.9%
Earnings Growth
1.72
Beta
0.39
Price / Book
$45.2B
Market Cap
$149.8B
$465 – $770
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →